Novartis, the global drug company, made a genomic analysis of Type 2 Diabetes (the fruits of its collaboration with several academic institutions) freely available on the Internet. A great number of scientists and researchers took advantage of this data to further their work. Many of them subsequently contacted Novartis to share their research and associated ideas and insights. This added to Novartis's pool of knowledge and provided it with additional avenues for the research and development of drug products. Also, because many of the scientists and researchers were keen to collaborate with Novartis, this research and development was done that much more quickly than otherwise.
By giving up exclusive ownership of information and encouraging as many people as possible to take and use it, Novartis increased its knowledge, quickened the process of research and development, increased and enhanced its links with leading researchers, and gained additional options for research that could lead to new and potentially lucrative drug products.
To see the full post click Here.
For more about collaboration go to: Sleeping-with-the-Enemy-Achieving-Collaborative-Success-2nd-Edition